Highbridge Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Hold |
254,265
| – | – | 0.01% | 133 |
|
|
2025
Q1 | $366K | Hold |
254,265
| – | – | 0.01% | 101 |
|
|
2024
Q4 | $559K | Hold |
254,265
| – | – | 0.02% | 135 |
|
|
2024
Q3 | $420K | Hold |
254,265
| – | – | 0.01% | 131 |
|
|
2024
Q2 | $564K | Buy |
+254,265
| New | +$564K | 0.02% | 104 |
|
|
2024
Q1 | – | Sell |
-221,722
| Closed | -$663K | – | 339 |
|
|
2023
Q4 | $663K | Sell |
221,722
-32,543
| -13% | -$97.3K | 0.03% | 100 |
|
|
2023
Q3 | $249K | Hold |
254,265
| – | – | 0.01% | 153 |
|
|
2023
Q2 | $353K | Hold |
254,265
| – | – | 0.02% | 136 |
|
|
2023
Q1 | $404K | Hold |
254,265
| – | – | 0.01% | 156 |
|
|
2022
Q4 | $1.58M | Sell |
254,265
-165,653
| -39% | -$1.03M | 0.04% | 211 |
|
|
2022
Q3 | $2.81M | Hold |
419,918
| – | – | 0.04% | 296 |
|
|
2022
Q2 | $2.67M | Hold |
419,918
| – | – | 0.06% | 307 |
|
|
2022
Q1 | $1.95M | Buy |
419,918
+74,323
| +22% | +$345K | 0.05% | 304 |
|
|
2021
Q4 | $1.73M | Buy |
+345,595
| New | +$1.73M | 0.04% | 307 |
|
|
2017
Q2 | – | Sell |
-31,064
| Closed | -$1.1M | – | 943 |
|
|
2017
Q1 | $1.1M | Buy |
+31,064
| New | +$1.1M | 0.02% | 500 |
|
|
2016
Q4 | – | Sell |
-11,976
| Closed | -$165K | – | 1084 |
|
|
2016
Q3 | $165K | Buy |
+11,976
| New | +$165K | ﹤0.01% | 952 |
|
|
2015
Q4 | – | Sell |
-236,669
| Closed | -$5.58M | – | 899 |
|
|
2015
Q3 | $5.58M | Buy |
+236,669
| New | +$5.58M | 0.09% | 243 |
|
|
2015
Q2 | – | Sell |
-94,527
| Closed | -$8.75M | – | 896 |
|
|
2015
Q1 | $8.75M | Buy |
+94,527
| New | +$8.75M | 0.12% | 205 |
|